NDC 52959-457 - Gabazolamine-0.5
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52959-457
- Package NDCs from labels
- 52959-457-30
- Manufacturer
- Physician Therapeutics LLC | Sandoz Inc | H.J. Harkins Company, Inc | Targeted Medical Pharma Inc.
- Effective date
- 2011-08-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabazolamine-0.5 | Physician Therapeutics LLC | Sandoz Inc | H.J. Harkins Company, Inc | Targeted Medical Pharma Inc. | 2011-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52959-457-30 | Gabazolamine-0.5 | 30 in 1 BOTTLE | TABLET | 30 | 0.5 mg | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Docusate Sodium | DOCUSATE SODIUM | A-S Medication Solutions | 5999904a-6ac8-4d9e-951c-6e64e8cd93eb | 2023-11-01 | Warnings | F05Q2T2JA0 |
| Sodium phenylacetate and Sodium benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Zydus Pharmaceuticals USA Inc. | 0f17c50f-3761-4470-bf3b-63837a287b8a | 2023-10-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Stool Softener Docusate Sodium | DOCUSATE SODIUM | Magno-Humphries, Inc. | a0e6ab9b-fd31-45fd-93d5-b51d705c180a | 2023-10-27 | Warnings | F05Q2T2JA0 |
| Stool Softener Docusate Sodium | DOCUSATE SODIUM | Magno-Humphries, Inc. | 9d22d642-8aed-d17e-e053-2995a90ae182 | 2023-10-27 | Warnings | F05Q2T2JA0 |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | Magno-Humphries, Inc. | 9deaf264-6af0-40ba-e053-2a95a90ada0e | 2023-10-27 | Warnings | F05Q2T2JA0 |
| DOK | DOCUSATE SODIUM | MAJOR PHARMACEUTICALS | 7a92070d-98cc-662f-e053-2991aa0aa1b2 | 2023-10-23 | Warnings | F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM | KROGER COMPANY | a1afaa71-7e8c-5a49-e053-2a95a90a4db0 | 2023-10-23 | Warnings | F05Q2T2JA0 |
| SENNA-S | SENNA AND DOCUSATE SODIUM TABLETS, 8.6 MG AND 50 MG | HealthLife of USA LLC | 02a5299c-4b0d-47ac-9838-afd0b0fdd4a6 | 2023-10-21 | Warnings | F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM | Geri-Care Pharmaceutical Corp | 644d81ec-d38f-4172-a087-727b94e2fefe | 2023-10-19 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | Asclemed USA, Inc. | 30fc8c07-c26b-4bcc-a727-6e193f5727fd | 2023-10-16 | Warnings | F05Q2T2JA0 |
| Stool Softener Extra Strength | DOCUSATE SODIUM | MEIJER, INC. | e43bd2ed-17c7-4530-af72-81a7ad70069c | 2023-10-12 | Warnings | F05Q2T2JA0 |
| Stool Softener Plus Stimulant Laxative | DOCUSATE SODIUM AND SENNOSIDES | Care One (Retail Business Services, LLC.) | 9adaec97-43e3-48f2-96c8-c508b693676c | 2023-10-05 | Warnings | F05Q2T2JA0 |
| Alprazolam | ALPRAZOLAM | Proficient Rx LP | 60c90b4b-174f-4fd2-b65f-fc166c16bdc1 | 2023-10-01 | Boxed warning, Warnings, Adverse reactions | 308047 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | Proficient Rx LP | 68e6ef8c-4104-4636-9719-6aa386c892d9 | 2023-10-01 | Boxed warning, Warnings, Adverse reactions | 308048 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | Aphena Pharma Solutions - Tennessee, LLC | f95f4030-e8e0-416f-951d-c4dac09f386a | 2023-09-15 | Boxed warning, Warnings, Adverse reactions | ANDA074112 308048 YU55MQ3IZY |
| Lipotox | SQUALENE, CHOLESTERINUM, ESTRADIOL, PROGESTERONE, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM, ARSENICUM ALBUM, LYCOPODIUM CLAVATUM, NUX VOMICA, PHOSPHORICUM ACIDUM, PHOSPHORUS, ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, PETROLEUM JELLY, PHENYL BUTAZONE, PLUMBUM METALLICUM, | BioActive Nutritional, Inc. | a1538692-ca00-4e52-9b7e-409767ee27e1 | 2023-09-05 | Warnings | OJ245FE5EU |
| Alprazolam | ALPRAZOLAM | Proficient Rx LP | 10de2b3b-3b3f-4a5a-a9e7-a8401f53b8cc | 2023-08-04 | Boxed warning, Warnings, Adverse reactions | 197321 YU55MQ3IZY |
| SODIUM PHENYLACETATE AND SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | MAIA PHARMACEUTICALS, INC | 3529be10-0004-4628-9ca1-67a8acd86b51 | 2023-07-05 | Warnings, Adverse reactions | OJ245FE5EU |
| Alprazolam | ALPRAZOLAM | ANI Pharmaceuticals, Inc. | 38428a1b-718c-49cc-94ae-2e3644ba6256 | 2023-06-28 | Boxed warning, Warnings, Adverse reactions | 197321 308047 197322 308048 YU55MQ3IZY |
| Alprazolam Extended Release | ALPRAZOLAM | Bryant Ranch Prepack | 4f6e4656-689f-46a6-a8ed-54ee55583357 | 2023-05-08 | Boxed warning, Warnings, Adverse reactions | YU55MQ3IZY |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.